Loading...
Nature's Sunshine Q1 2025 Earnings Report
Nature's Sunshine reported strong financial results for the first quarter ended March 31, 2025, with increased net sales, net income, and adjusted EBITDA.
Key Takeaways
Nature's Sunshine Products, Inc. reported a strong first quarter for 2025, with net sales increasing 2% to $113.2 million, and GAAP net income attributable to common shareholders rising 104% to $4.7 million. Adjusted EBITDA also saw a significant increase of 20% to $11.0 million.
Net sales increased 2% to $113.2 million, or 5% in constant currency, compared to $111.0 million in the prior year quarter.
GAAP net income attributable to common shareholders surged 104% to $4.7 million, or $0.25 per diluted common share, up from $2.3 million, or $0.12 per diluted common share.
Adjusted EBITDA grew 20% to $11.0 million, compared to $9.2 million in the same period last year.
The company's board of directors authorized a new share repurchase program of up to $25 million, in addition to the $8.3 million remaining from the previous authorization.
Nature's Sunshine
Nature's Sunshine
Nature's Sunshine Revenue by Geographic Location
Revenue by Geographic Location
Asia Revenue
CapyFin.comEurope Revenue
CapyFin.comNorth America Revenue
CapyFin.comLatin America and Other Revenue
CapyFin.com Forward Guidance
Nature's Sunshine expects full year 2025 net sales to range between $445 million and $470 million, and adjusted EBITDA to range between $38 million and $44 million.
Positive Outlook
- Continued strong growth expected in Asia and Europe, particularly in Taiwan, Japan, and Central Europe.
- Early signs of stabilization in North America are expected to continue.
- Continued improvements to gross margin are anticipated.
- Confidence in the underlying health of the business and global growth strategies.
- Disciplined investments with high potential return for shareholders, supported by share repurchase authorization.
Challenges Ahead
- Tremendous amount of uncertainty in the market could impact future performance.
- Potential for fluctuating foreign exchange rates to affect financial results.
- Risks associated with supply chain disruptions, manufacturing interruptions, or delays.
- Potential for increased liability and compliance costs related to the China joint venture.
- Uncertainties related to the application of transfer pricing, duties, and other tax regulations.
Revenue & Expenses
Visualization of income flow from segment revenue to net income